Details for Patent: 8,349,294

✉ Email this page to a colleague

Summary for Patent: 8,349,294

Patent landscape, scope, and claims:

Title:	Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
Abstract:	Microparticle compositions comprising metal ion-lipid complexes for drug delivery are described including methods of making the microparticle compositions and methods of treating certain conditions and disease states by administering the microparticle compositions. The metal ion-lipid complexes can be combined with various drugs or active agents for therapeutic administration. The microparticle compositions of the present invention have superior stability to other microparticle compositions resulting in a microparticle composition with longer shelf life and improved dispersability. The microparticle compositions of the present invention have a transition temperature (T.sub.g) of at least 20.degree. C. above the recommended storage temperature (Tst) for drug delivery.
Inventor(s):	Dellamary; Luis A (San Marcos, CA), Riess; Jean (Falicon, FR), Schutt; Ernest G (San Diego, CA), Weers; Jeffry G (Belmont, CA), Tarara; Thomas E (Burlingame, CA)
Assignee:	Novartis AG (Basel, CH)
Application Number:	12/967,482
Patent Claim Types: see list of patent claims	Composition; Delivery;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 8,349,294

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,349,294

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1280520	⤷ Subscribe	C300722	Netherlands	⤷ Subscribe
European Patent Office	1280520	⤷ Subscribe	CA 2015 00017	Denmark	⤷ Subscribe
European Patent Office	1280520	⤷ Subscribe	92678	Luxembourg	⤷ Subscribe
European Patent Office	1280520	⤷ Subscribe	300722	Netherlands	⤷ Subscribe
European Patent Office	1280520	⤷ Subscribe	14/2015	Austria	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.